Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| TOTAL | $84 | $148 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $84 | $148 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 26 | 28 | 69 | 60 | N/A |
| Accounts payable and accrued liabilities | 1,157 | 1,056 | 931 | 843 | 997 |
| Accrued Expenses | 223 | 224 | 227 | 225 | 224 |
| TOTAL | $1,709 | $1,616 | $1,533 | $1,434 | $1,277 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,709 | $1,616 | $1,533 | $1,434 | $1,277 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,241,106 | 1,241,106 | 1,162,921 | 1,026,417 | 934,889 |
| Common Shares | 1,241 | 1,163 | 1,050 | 996 | 872 |
| Retained earnings | -21,023 | -20,825 | -20,650 | -20,454 | -20,104 |
| Other shareholders' equity | 179 | 179 | 0 | 0 | 33 |
| TOTAL | $-1,625 | $-1,469 | $-1,533 | $-1,434 | $-1,277 |
| Total Liabilities And Equity | $84 | $148 | $0 | $0 | $0 |